About > FAQ > MindSpec
What is MindSpec?
MindSpec is a not-for-profit organization established to accelerate autism research. We develop new tools to integrate research information about autism from diverse scientific disciplines.
What does MindSpec offer?
We have developed a searchable database on autism, AutDB. AutDB is a cutting-edge resource to facilitate communication between scientists, clinicians and anyone affected by autism. We aim to offer an unbiased, dynamic, up-to-date, full range view of autism.
Who is involved at MindSpec?
Sharmila Banerjee Basu, Ph.D. founded the organization in 2006 and is currently its CSO and President. MindSpec currently has 5 members in its scientific advisory board and 10 members in its operations team.
Whom do I contact with questions about MindSpec and AutDB?
Where is MindSpec located?
We are located in McLean, Virginia, a suburb of Washington, DC. This positions us near major scientific research centers, including the National Institutes of Health, the Maryland biotechnology corridor, and numerous academic institutions such as Georgetown University, George Washington University, George Mason University, and The Johns Hopkins University.
Our street address is 8280 Greensboro Dr, Suite 150, McLean, VA, 22102.
Who funds MindSpec’s research?
We receive funding from a combination of private grants, software licensing, and charitable donations. Our autism database, AutDB, is currently funded by the Simons Foundation.
How can I support MindSpec?
We host an annual benefit every fall. Please watch our website for future announcements, or contact us for details. We also welcome donations by direct mail to MindSpec at 8280 Greensboro Dr, Suite 150, McLean VA. MindSpec is an IRS-certified 501(c)3 tax-exempt organization, and all donations are tax-deductible.
The MindSpec logo says “informatics for neurodevelopmental disorders” but I only see information relating to autism spectrum disorders. Does MindSpec also conduct research on other neurological conditions?
We are currently creating innovative bioinformatics tools for other neurodevelopmental disorders, which we hope to release soon.